ChemedvsJohnson & Johnson

CHE and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

CHE

Chemed Corp

$549.45

Value $7.2B

+0.23%
CHE's page

Chemed (CHE) has a market value of $7.2B and Johnson & Johnson (JNJ) $681B. Over the last year, with dividends, CHE moved +27.0% and JNJ +47.5%. The P/E is 25.3 for CHE and 42.3 for JNJ. Dividend yield: CHE 0.46%, JNJ 1.87%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CHE$7.2B

    JNJ$681B

    JNJ is 95 times CHE

  • Revenue, 12 months

    CHE$2.7B

    JNJ$99.3B

    JNJ is 37 times CHE

  • Net income, 12 months

    CHE$282M

    JNJ$16.1B

    JNJ is 57 times CHE

  • Operating margin

    CHE13.9%

    JNJ–

  • ROIC

    CHE26.5%

    JNJ12.4%

    14.1 points apart

  • P/E

    CHE25.3

    JNJ42.3

    JNJ is 1.7 times CHE

  • Dividend yield

    CHE0.5%

    JNJ1.9%

    1.4 points apart

  • 5-year return

    CHE+12.3%

    JNJ+98.6%

    86.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CHE+12.3%

JNJ+98.6%

10015020020222023202420252026
Returns by period
PeriodCHEWith dividendsJNJWith dividends
1 year since November 14, 2025+27.0%Price +26.1%+47.5%Price +44.2%
3 years since November 16, 2023-5.0%-1.7% a yearPrice -6.2%+105.0%+27.0% a yearPrice +88.2%
5 years since November 15, 2021+12.3%+2.3% a yearPrice +10.2%+98.6%+14.7% a yearPrice +72.8%
10 years since November 16, 2016+291.1%+14.6% a yearPrice +276.9%+218.6%+12.3% a yearPrice +142.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CHEChemedJNJJohnson & Johnson

Valuation

CHEJNJ
Valuation
Price$549.45$282.55
Market value$7.2B$681B
Enterprise value (EV)$7.3B$708B
P/E25.342.3
P/E, 5-year median30.921.9
P/B8.38.4
EV/EBIT19.839.9
Free cash flow yield4.1%3.0%

Results and growth

CHEJNJ
Results and growth
Revenue, 12 months$2.7B$99.3B
Net income, 12 months$282M$16.1B
Free cash flow, 12 months$296M$20.6B
Earnings per share, 12 months$20.87$6.59
Revenue growth, year on year4.1%6.1%
Revenue growth a year, past+4.0%over 5 years+2.7%over 5 years
EPS growth a year, past-1.2%over 5 years+14.9%over 5 years

Margins and returns on capital

CHEJNJ
Margins and returns on capital
Gross margin33.5%67.6%
Operating margin13.9%–
Net margin10.6%16.2%
ROIC26.5%12.4%
ROE30.7%19.7%

Balance sheet

CHEJNJ
Balance sheet
Cash$48M$17.2B
Total debt$392M$44.7B
Net debt / EBITDA0.41.1
Interest cover75.4×18.0×

Dividends and buybacks

CHEJNJ
Dividends and buybacks
Dividend yield0.5%1.9%
Dividend per share, 12 months$2.50$5.28
Dividend growth a year, past+10.8%over 5 years+5.3%over 5 years
Buyback yield6.0%0.9%
Shareholder yield6.5%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CHE or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Chemed or Johnson & Johnson?

By market value, Johnson & Johnson ($681B) is about 95.2 times Chemed ($7.2B), at today's prices.

How did CHE and JNJ stock do over the last 10 years?

Since November 16, 2016, CHE's price moved +276.9% and JNJ's +142.8%. With dividends: CHE +291.1% (+14.6% a year), JNJ +218.6% (+12.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, CHE or JNJ?

The dividend yield at today's price is 0.46% for Chemed and 1.87% for Johnson & Johnson. Over the last twelve months they paid $2.50 and $5.28 per share.

What is the P/E of CHE and JNJ?

At today's price, the P/E is 25.3 for CHE and 42.3 for JNJ. The median of the last five years was 30.9 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Chemed or Johnson & Johnson?

Over the last twelve months, the net margin was 10.6% for Chemed and 16.2% for Johnson & Johnson, and the operating margin 13.9% and –. Revenue was $2.7B and $99.3B.

Which is the better investment, Chemed or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.